SCI时时刷

search
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that can significantly affect quality of life. Presence, se...
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea
Pityriasis rosea (PR) is a prevalent dermatological condition characterized by a distinctive herald patch, followed by sec...
A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis
A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis
Ruxolitinib cream has demonstrated anti-inflammatory and antipruritic activity and was well tolerated in a phase 3 study i...